(PDF) Bisphosphonates and Nonhealing Femoral Fractures:

Bisphosphonates and Nonhealing Femoral Fractures: Analysis of the FDA Adverse Event Reporting System (FAERS) and International Safety Efforts

Journal of Bone and Joint Surgery - Series A - United States

doi 10.2106/jbjs.k.01181

Full Text

Open PDF

Abstract

Available in full text

Date

February 1, 2013

Authors

Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Serious Adverse Drug Events Reported to the Food and Drug Administration (FDA): Analysis of the FDA Adverse Event Reporting System (FAERS) 2006-2011 Database

English

Prm79 - Weber Effect: An Extended Analysis for Ten Years of Reporting Trends in Fda Adverse Event Reporting System (Faers)

English

Safety of Biologics Approved for the Treatment of Rheumatoid Arthritis and Other Autoimmune Diseases: A Disproportionality Analysis From the FDA Adverse Event Reporting System (FAERS)

English

Clustering Therapeutic Drugs Using FDA Adverse Event Reporting System

Proceedings for Annual Meeting of The Japanese Pharmacological Society

2020

English

Association Between Myocarditis and Other Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitor Use: Analysis of the FDA Adverse Events Reporting System (FAERS)

Journal of Cardiac Failure

Cardiovascular Medicine

Cardiology

2019

English

Adverse Events Associated With Pediatric Use of Proton Pump Inhibitors: Analysis of the Fda Adverse Event Reporting System

English

Adverse Events Associated With Colchicine Drug Interactions: Analysis of the Public Version of the Fda Adverse Event Reporting System

English

Pmh6 - Lurasidone Induced Suicidal Ideation and Hallucination: Disproportionality Analysis in Fda Adverse Event Reporting System Database

English

Performance of Pharmacovigilance Signal-Detection Algorithms for the FDA Adverse Event Reporting System

Clinical Pharmacology and Therapeutics

Pharmacology

2013

English

Amanote Research

Bisphosphonates and Nonhealing Femoral Fractures: Analysis of the FDA Adverse Event Reporting System (FAERS) and International Safety Efforts

Journal of Bone and Joint Surgery - Series A - United States

doi 10.2106/jbjs.k.01181

Full Text

Abstract

Categories

Date

Authors

Publisher

Related search

Serious Adverse Drug Events Reported to the Food and Drug Administration (FDA): Analysis of the FDA Adverse Event Reporting System (FAERS) 2006-2011 Database

Prm79 - Weber Effect: An Extended Analysis for Ten Years of Reporting Trends in Fda Adverse Event Reporting System (Faers)

Safety of Biologics Approved for the Treatment of Rheumatoid Arthritis and Other Autoimmune Diseases: A Disproportionality Analysis From the FDA Adverse Event Reporting System (FAERS)

Clustering Therapeutic Drugs Using FDA Adverse Event Reporting System

Association Between Myocarditis and Other Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitor Use: Analysis of the FDA Adverse Events Reporting System (FAERS)

Adverse Events Associated With Pediatric Use of Proton Pump Inhibitors: Analysis of the Fda Adverse Event Reporting System

Adverse Events Associated With Colchicine Drug Interactions: Analysis of the Public Version of the Fda Adverse Event Reporting System

Pmh6 - Lurasidone Induced Suicidal Ideation and Hallucination: Disproportionality Analysis in Fda Adverse Event Reporting System Database

Performance of Pharmacovigilance Signal-Detection Algorithms for the FDA Adverse Event Reporting System